Antibiotics and Gut Health: Clinical Implications and Recovery Strategies
Antibiotics and gut health are closely linked because antibiotics disrupt the balance of bacteria in the intestinal microbiome. While...
Phage Therapy: How Bacteriophages Are Transforming Infection Treatment
Phage therapy is an innovative medical treatment that uses viruses called bacteriophages to destroy harmful bacteria. As antibiotic resistance...
Hurler Syndrome Gene Therapy: Shows Success in a Small Study
Hurler syndrome (also called mucopolysaccharidosis type 1, Hurler variant [MPSIH]), is a genetic disorder that causes abnormal musculoskeletal development,...
Genome Sequencing Project – Answers for Rare Disease
Some patients with a suspected rare genetic disease go without a diagnosis for years or even throughout a lifetime....
How to know the status of acute lymphoblastic leukemia from epigenetic DNA modification?
Hematological cancers were among the first to be discovered to have abnormal demethylation status. Excretion of epigenetic DNA modification...
Using viruses to outsmart antibiotic-resistant bacteria
Phage therapy – the treatment of bacterial infections with viruses that attack those bacteria – was used in the...
Recent developments in primary hyperoxaluria treatment
Primary hyperoxaluria (PH) is a rare genetic disease in which high levels of oxalate are produced and can deposit...
Cancer vaccines in the clinic and in trials
Most vaccines are given as prophylactics, agents that protect healthy individuals before exposure to a pathogen. By contrast, therapeutic...
GLP-1 receptor agonists and/or DPP4 inhibitors: Diabetes drugs may lower the risk of Parkinson’s disease
Parkinson’s disease, the most common neurodegenerative movement disorder has growing prevalence with the age. Due to increasing life expectancy...
Liraglutide demonstrated CV benefits among Diabetes Drugs
Liraglutide (Victoza®) is an injectable glucagon-like peptide-1 (GLP-1) receptor antagonist indicated in addition to diet and exercise to improve...